Cargando…

Inhibiting the molecular evolution of cancer through HSP90

Detalles Bibliográficos
Autores principales:	Martins, Ana Sofia, Davies, Faith E, Workman, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717948/ https://www.ncbi.nlm.nih.gov/pubmed/23175477

Ejemplares similares

Blocking the survival of the nastiest by HSP90 inhibition
por: Workman, Paul, et al.
Publicado: (2016)

Evolution of kinase polypharmacology across HSP90 drug discovery
por: Antolin, Albert A., et al.
Publicado: (2021)

Hsp90 Promotes Kinase Evolution
por: Lachowiec, Jennifer, et al.
Publicado: (2015)

Distinct Roles of Molecular Chaperones HSP90α and HSP90β in the Biogenesis of KCNQ4 Channels
por: Gao, Yanhong, et al.
Publicado: (2013)

Heterologous Hsp90 promotes phenotypic diversity through network evolution
por: Koubkova-Yu, Tracy Chih-Ting, et al.
Publicado: (2018)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

Circumventing HSP90 inhibitors via apoptosis block
por: Fennell, Dean A., et al.
Publicado: (2015)

Gaining new insights on the Hsp90 regulatory network
por: Piva, Francesco, et al.
Publicado: (2020)

Role of HSP90 in Cancer
por: Birbo, Bereket, et al.
Publicado: (2021)

An Editorial on the Special Issue ‘Hsp90 Structure, Mechanism and Disease’
por: Prodromou, Chrisostomos
Publicado: (2023)

Silencing the cochaperone CDC37 destabilises kinase clients and sensitises cancer cells to HSP90 inhibitors
por: Smith, Jennifer R., et al.
Publicado: (2008)

Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole
por: Liu, Zhelong, et al.
Publicado: (2021)

USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer
por: Kosinsky, Robyn Laura, et al.
Publicado: (2019)

C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
por: Fan, Yingjuan, et al.
Publicado: (2017)

The Chaperone System in Breast Cancer: Roles and Therapeutic Prospects of the Molecular Chaperones Hsp27, Hsp60, Hsp70, and Hsp90
por: Alberti, Giusi, et al.
Publicado: (2022)

WISp39 and Hsp90: actin' together in cell migration
por: Fotedar, Rati, et al.
Publicado: (2015)

Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1
por: Park, Hye-Kyung, et al.
Publicado: (2020)

Targeting HSF1 sensitizes cancer cells to HSP90 inhibition
por: Chen, Yaoyu, et al.
Publicado: (2013)

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
por: Usmani, Saad Z, et al.
Publicado: (2010)

Targeting HSP90 for cancer therapy
por: Mahalingam, D, et al.
Publicado: (2009)

The interplay between inhibition of JAK2 and HSP90
por: Fridman, Jordan S., et al.
Publicado: (2012)

Review: The HSP90 molecular chaperone—an enigmatic ATPase
por: Pearl, Laurence H.
Publicado: (2016)

Hsp90 Inhibition Decreases Mitochondrial Protein Turnover
por: Margineantu, Daciana H., et al.
Publicado: (2007)

Hsp90 Inhibitor Can Inhibit UV-Carcinogenesis
por: Katiyar, Santosh K.
Publicado: (2015)

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
por: Nizami, Sohaib, et al.
Publicado: (2020)

Hsp90 inhibition sensitizes DLBCL cells to cisplatin
por: Schmidt, Linnéa, et al.
Publicado: (2022)

Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function
por: Collins, Colm B., et al.
Publicado: (2013)

Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer
por: Zhang, Liyuan, et al.
Publicado: (2016)

Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stress()
por: Zhang, Lei, et al.
Publicado: (2013)

Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90
por: Ma, Ji, et al.
Publicado: (2023)

Molecular Chaperone Hsp90 Is a Therapeutic Target for Noroviruses
por: Vashist, Surender, et al.
Publicado: (2015)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Hsp90 inhibition protects against inherited retinal degeneration
por: Aguilà, Mònica, et al.
Publicado: (2014)

Conformational dynamics modulate the catalytic activity of the molecular chaperone Hsp90
por: Mader, Sophie L., et al.
Publicado: (2020)

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins
por: Smith, Jennifer R., et al.
Publicado: (2013)

Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer
por: Zagouri, Flora, et al.
Publicado: (2012)

Molecular Dynamics Simulations of Hsp90 with an Eye to Inhibitor Design
por: Moroni, Elisabetta, et al.
Publicado: (2012)

Hsp-90 and the biology of nematodes
por: Him, Nik AIIN, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dk35heg3t3bkuofp8vle8i7n7k